Atlas Trials

Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ

Clinical trial NCT00914342 · COMPLETED

Trial details

NCT number
NCT00914342
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Gastroesophageal Reflux Disease
Start date
2009-07-01
Enrollment
889

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.